NCT00660361View on ClinicalTrials.gov

A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

UnknownOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

September 30, 2010

Conditions
HIV InfectionsHepatitis B Virus
Trial Locations (1)

3004

RECRUITING

The Alfred Hospital, Melbourne

Sponsors

Lead Sponsor

Bayside Health

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Bayside Health

OTHER_GOV